Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :12471
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Eribulin in Recurrent/Metastatic Breast Cancer (MBC)
Taha Sethjiwala,Manikandan Dhanushkodi,Venkatraman Radhakrishnan,Jayachandran Perumal Kalaiarasi,Nikita Mehra,Archit Joshi,Arun Kumar Rajan,Gangothri Selvarajan,Balasubramanian Ananthi,Priya Iyer,Geetha Senguttuvan,Bharathi Srilatha,Arvind Krishnamurthy,Sridevi Velusamy,Selvaluxmy Ganesarajah,Trivadi S. Ganesan,Tenali Gnana Sagar
Indian Journal of Gynecologic Oncology.2019;17(3)
[DOI]
2Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience
BJ Srinivasa,Bhanu Prakash Lalkota,Girish Badarke,Diganta Hazarika,Nasiruddin Mohammad,Sulav Sapkota,Mansi Khanderia,D Tousif,Raghavendra Rao,Amritanshu Ram,Shekar Patil,Radheshyam Naik
Clinical Medicine Insights: Oncology.2018;12(3)117955491878247
[DOI]
3A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer
Ioannis A. Voutsadakis
Anti-Cancer Drugs.2017;28(5)557
[DOI]
4Eribulin across multiple lines of chemotherapy: a retrospective study on quality of life and efficacy in metastatic breast cancer patients
Erica Quaquarini,Federico Sottotetti,Daniela D’Ambrosio,Alberto Malovini,Stefania Morganti,Arianna Marinello,Lorenzo Pavesi,Mara Frascaroli
Future Oncology.2017;13(11s)11
[DOI]
5Eribulin efficacy based on type of metastatic site: a real-life study in heavily pretreated metastatic breast cancer
Angela Prestifilippo,Daniele Grippaldi,Giusi Blanco,Lorenzo Memeo,Ivana Puliafito,Dario Giuffrida
Future Oncology.2017;13(11s)5
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow